Status:
COMPLETED
Value of PCT When Diagnosing Candidemia
Lead Sponsor:
Karolinska University Hospital
Conditions:
The Value of Procalcitonin in Patients With Suspected Candidemia
Eligibility:
All Genders
18+ years
Brief Summary
This study is a retrospective analysis to identify and compare the shift in inflammatory biomarkers in ICU patients immediately before and after the first identification of candidemia.
Detailed Description
As above.
Eligibility Criteria
Inclusion
- Inclusion Criteria (all has to be fullfilled):
- ICU patients with blood cultures showing growth of Candida species
- clinical records including daily data on WBC, CRP, Procalcitonin and body temperature
- Exclusion Criteria:
- Age lower than 18 years
- blood cultures with growth of Candida species before ICU admission
- incomplete records of daily WBC, CRP, Procalcitonin or body temperature
Exclusion
Key Trial Info
Start Date :
April 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 12 2021
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT05385107
Start Date
April 1 2010
End Date
December 12 2021
Last Update
May 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital Solna
Stockholm, Sweden, 17176